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ABSTRACT We previously reported that mice deficient in UDP-GlcNAc:lysosomal enzyme 
GlcNAc-1-phosphotransferase (mucolipidosis type II or Gnptab −/− mice), the enzyme that 
initiates the addition of the mannose 6-phosphate lysosomal sorting signal on acid hydrolases, 
exhibited extensive vacuolization of their exocrine gland cells, while the liver, brain, and mus-
cle appeared grossly unaffected. Similar pathological findings were observed in several exo-
crine glands of patients with mucolipidosis II. To understand the basis for this cell type–specif-
ic abnormality, we analyzed these tissues in Gnptab −/− mice using a combined immunoelectron 
microscopy and biochemical approach. We demonstrate that the vacuoles in the exocrine 
glands are enlarged autolysosomes containing undigested cytoplasmic material that accumu-
late secondary to deficient lysosomal function. Surprisingly, the acid hydrolase levels in these 
tissues ranged from normal to modestly decreased, in contrast to skin fibroblasts, which ac-
cumulate enlarged lysosomes and/or autolysosomes also but exhibit very low levels of acid 
hydrolases. We propose that the lysosomal defect in the exocrine cells is caused by the com-
bination of increased secretion of the acid hydrolases via the constitutive pathway along with 
their entrapment in secretory granules. Taken together, our results provide new insights into 
the mechanisms of the tissue-specific abnormalities seen in mucolipidosis type II.
INTRODUCTION
Mucolipidosis type II (MLII, inclusion-cell disease or I-cell disease) is 
an autosomal recessive disorder due to deficiency of UDP-
GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase (GlcNAc-
1-phosphotransferase), the first enzyme involved in the synthesis of 
the mannose 6-phosphate (Man-6-P) signal, which allows the spe-
cific targeting of lysosomal acid hydrolases from the trans-Golgi net-
work (TGN) to lysosomes (Kornfeld and Sly, 2000; Pohl et al., 2009; 
Cathey et al., 2010; Kollmann et al., 2010). The fibroblasts of MLII 
patients have been shown to hypersecrete most of their newly syn-
thesized acid hydrolases via the constitutive secretory pathway, 
thereby accounting for the deficiency of acid hydrolases in these 
cells and, at least partially, for the high level of these same hydro-
lases in the extracellular fluids of the patients (Leroy and Demars, 
1967; Lightbody et al., 1971; Tondeur et al., 1971; Wiesmann et al., 
1971a, 1971b; Hickman and Neufeld, 1972; Leroy et al., 1972; Aula 
et al., 1975; Martin et al., 1975). At the morphological level, the 
most striking alterations have been found in these fibroblasts and 
other cell types of mesenchymal origin, which develop a lysosomal 
storage phenotype characterized by the accumulation of phase-
dense inclusions that gave rise to the term “inclusion-cell disease” 
(Leroy and DeMars, 1967; Kenyon and Sensenbrenner, 1971; Aula 
et al., 1975; Martin et al., 1975; Nagashima et al., 1977). By contrast, 
other cell types exhibit few, if any, morphological alterations, includ-
ing most cells of the hepatic parenchyma, CNS, and muscle (Kenyon 
et al., 1973; Martin et al., 1975, 1984; Nagashima et al., 1977). Inter-
estingly, a more recent report described striking vacuolization at a 
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accumulation of autophagosomes in mouse embryonic fibroblasts 
and macrophages, resulting from defective autophagosome–lyso-
some fusion (Settembre et al., 2008). We therefore asked whether a 
similar block in autophagy might be occurring in the Gnptab −/− 
submandibular gland. The large vacuoles filled with undegraded 
cytoplasmic material that accumulate in the Gnptab −/− mucous 
cells were surrounded by a single membrane (Figure 1, C and D) 
and, as shown in Figure 1D, LAMP-2 was readily detected by cryo-
immunogold EM in their limiting membrane. These observations 
indicate that they represent autolysosomes formed by fusion of au-
tophagic compartments with lysosomes. In this regard, these results 
differ from the accumulation of autophagosomes reported in the 
other lysosomal storage disorders.
Interestingly, we observed numerous fusion profiles of mucous 
granules with the autolysosomes, consistent with ongoing 
crinophagy, an autophagic process by which secretory granules di-
rectly fuse with lysosomes or autolysosomes (Figure 1, E and F, ar-
rows) (Smith and Farquhar, 1966). We also found mucous secretory 
granules that were being engulfed by autolysosomes, a process de-
scribed as microautophagy (Figure 1, E and G, arrowhead) (Cuervo, 
2004).
In addition to the salivary gland, the exocrine pancreas of the 
Gnptab −/− mice also exhibited a clear vacuolization under the light 
microscope (Gelfman et al., 2007; Vogel et al., 2009). EM analysis 
revealed that the acinar cells of this organ, which are serous-type 
secretory cells, were similarly affected by the loss of the Man-6-P 
targeting pathway. In the wild-type pancreas, LAMP-2 localized to 
normal sized lysosomes with a diameter of ∼300–600 nm (Figure 2A). 
By contrast, the Gnptab −/− serous cells exhibited an accumulation 
of large LAMP-2 positive compartments, which had an approximate 
diameter of 500 nm to 2 μm and were filled with undegraded cyto-
plasmic material (Figure 2, B-D). Mitochondrial remnants were regu-
larly observed in the lumen of these compartments (Figure 2B) and 
undigested secretory granules were occasionally detected (Figure 
2, C and D). Therefore, as in the salivary gland, these compartments 
could be identified as autolysosomes on the basis of their content 
and membrane protein composition. LAMP-2 negative autophago-
somes were also occasionally observed (unpublished data). Consis-
tent with the accumulation of LAMP-2 positive autolysosomes, the 
level of LAMP-2 as determined by Western blotting was markedly 
increased in the Gnptab −/− pancreas, as well as in the mutant pa-
rotid, sublingual, and submandibular salivary glands (Figure 3A). In 
contrast, the brain, liver, and muscle exhibited normal levels of 
LAMP-2 in the mutant mouse compared with wild-type (Figure 3A). 
Of note, the secretory granules in the Gnptab −/− pancreatic acinar 
cells appeared similar to those of the wild-type cells in shape and 
density (Figure 2, E and F) but were smaller in size (∼27% smaller 
compared with wild type).
Gnptab −/− exocrine glands lack signs of a strong induction 
of macroautophagy
One mechanism that could lead to the accumulation of autolyso-
somes in the salivary and pancreatic glands of the Gnptab −/− 
mice would be an enhanced activation of the autophagy process 
that might overwhelm the lysosomal degradative capacity. To ad-
dress this possibility, we determined the levels of Beclin-1 and the 
activity of the serine/threonine kinase mTOR (target of rapamycin) 
in the salivary glands and pancreas of the Gnptab −/− and wild-
type mice. Beclin-1 and mTOR are key regulators in the process of 
macroautophagy (Pattingre et al., 2008). Increased levels of Be-
clin-1, which is part of a PI(3)-kinase complex, activate and up-reg-
ulate the process of autophagy through its interaction with hVps34 
novel site: the serous secretory cells of the pancreas and salivary 
glands of several infants with MLII (Elleder and Martin, 1998). In that 
study, the origin of the vacuoles was not explained and the acid 
hydrolase content of these tissues was not determined. During the 
course of studying mice mutant in the gene Gnptab, which encodes 
the α/β catalytic subunits of GlcNAc-1-phosphotransferase (MLII 
mouse model), we observed similar vacuolization in the exocrine 
secretory cell types (Gelfman et al., 2007; Vogel et al., 2009). This 
finding provided the opportunity to investigate the nature and 
cause of this pathological alteration.
In this article, we demonstrate that the vacuolization of the acinar 
cells of the pancreatic and salivary glands of Gnptab −/− mice (or 
MLII mice) seen by light microscopy represents the accumulation of 
numerous, large autolysosomes, involved in crino-, micro-, and mac-
roautophagy. Interestingly, enzymatic assays revealed that these 
glands have only a modest decrease in acid hydrolase content, in 
contrast to the major deficiency exhibited by the skin fibroblasts 
derived from the mutant mice, in which we also detected an accu-
mulation of enlarged lysosomes and/or autolysosomes by electron 
microscopy. On the basis of our findings and the current under-
standing of the special role of the Man-6-P recognition system in 
secretory cells, we propose that the lack of Man-6-P signals on the 
acid hydrolases results in their entrapment within exocrine gland 
secretory granules as well as increased secretion and, consequently, 
in lysosomal dysfunction. These results suggest that hypersecretion 
of acid hydrolases via the constitutive secretory pathway may not be 
the only cause for the development of lysosomal insufficiency in 
mucolipidosis II mice and patients.
RESULTS
Vacuolization of the acinar cells of the salivary glands 
and pancreas of Gnptab −/− mice represents accumulation 
of autolysosomes
The acini of the exocrine salivary glands, which consist of mucous- 
and serous-type secretory cells, exhibited extensive vacuolization in 
Gnptab −/− mice when examined by light microscopy (Gelfman 
et al., 2007; Vogel et al., 2009). To gain insight into the underlying 
pathology, we analyzed the submandibular salivary gland of these 
mice by electron microscopy (EM). Both mucous- and serous-type 
secretory cells were readily observed in the wild-type mice 
(Figure 1A). By contrast, the overall architecture of the submandibu-
lar salivary gland of the Gnptab −/− mice was so grossly disrupted 
that it greatly hampered the identification of the serous cells in the 
EM sections (Figure 1B). The mucous-type secretory cells, however, 
could be recognized by their characteristic electron lucent secretory 
granules (average diameter size ∼800 nm). These cells were packed 
with large (up to ∼4 μm in diameter) membrane-bound vacuoles that 
contained heterogeneous material (Figure 1B arrowheads, higher 
magnification in Figure 1C), which accounted for the extensive vacu-
olization observed by light microscopy. Detailed morphological 
analysis of these vacuoles in Gnptab −/− mucous cells showed that 
they often contained material reminiscent of undigested cytoplas-
mic organelles, particularly mitochondria (Figure 1D), suggesting a 
defect in the autophagic pathway.
Macroautophagy (hereafter referred to as autophagy), which is 
the most prevalent type of autophagy in most tissues, starts with the 
sequestration of cargo destined for degradation in a large double-
membrane vesicle, the autophagosome. The fusion of the autopha-
gosome with a lysosome gives rise to an autolysosome, where deg-
radation of the cargo takes place (Cao and Klionsky, 2007). Recent 
studies of the lysosomal storage disorders “multiple sulfatase defi-
ciency” and “mucopolysaccharidosis type IIIA” in mice reported the 
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FIGUrE 1: Autolysosomes accumulate in the submandibular salivary gland of Gnptab −/− mice. (A) Electron 
micrograph showing a low-magnification overview of a wild-type (WT) mouse submandibular salivary gland acinus, 
composed of mucous and serous cells. (B) Overview of a Gnptab −/− submandibular salivary gland acinus. The overall 
architecture is disrupted by the massive accumulation of large vacuoles with diameter sizes up to ∼4 μm (arrowheads). 
Mucous-type secretory cells are recognized by the presence of the electron lucent secretory granules (average diameter 
size ∼800 nm). (C) Higher magnification of a vacuole from (B), which is surrounded by a single membrane and contains 
undegraded material. Area of magnification is indicated by the box in (B). (D, E) Further characterization of the vacuoles 
that accumulate in the Gnptab −/− submandibular salivary gland shows the presence of the lysosomal membrane 
protein LAMP-2 in their limiting membrane by immunogold labeling (D, 10-nm gold particles), mitochondria inside their 
lumen (D), fusion with (E, arrows) and engulfment (E, arrowhead) of mucous secretory granules (crinophagy and 
microautophagy events, respectively). Taken together, these observations define these vacuoles as autolysosomes. 
Higher magnifications of the (F) crinophagy and (G) microautophagy events shown in (E). Areas of magnification are 
indicated by the boxes in (E). AL, autolysosome; M, mitochondrion; Mu, mucous cell; N, nucleus; S, serous cell; SG, 
secretory granule.
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these same tissues compared with wild-type animals (Figure 4A). 
These data indicate that, while the process of autophagy may be 
stimulated via the Beclin-1 pathway in the mutant cells, at the same 
time it is being inhibited by the activation of the mTOR pathway. 
Taken together, these observations suggest that macroautophagy 
is not strongly enhanced in these tissues. In accordance with this 
observation, evaluation of the occurrence of autophagosomes in 
EM sections of Gnptab −/− and wild-type pancreas did not reveal 
a significant increase in the number of these organelles in the mu-
tant mice compared with wild-type (1.1 ± 0.2 autophagosomes per 
Gnptab −/− cell profile compared with 0.6 ± 0.1 for wild-type, 
p = 0.11) (Figure 4B). In contrast, the marked increase in the 
(Cao and Klionsky, 2007). The mTOR (kinase complex 1) is a central 
element in several sensing-signaling pathways that regulate cellu-
lar processes such as cell growth, nutrient import, protein synthe-
sis, and autophagy (Pattingre et al., 2008). It has been reported 
that, under various stress conditions, the inhibition of mTOR results 
in up-regulation of autophagy (Pattingre et al., 2008; Jung et al., 
2010). We analyzed the activity of mTOR in the Gnptab −/− tissues 
by measuring the phosphorylation level of one of its downstream 
targets, the ribosomal kinase S6K (p70S6K). Our analysis showed 
that the level of Beclin-1 was slightly elevated in the Gnptab −/− 
exocrine glands (with the exception of the sublingual gland), 
whereas the phosphorylation of p70S6K was highly increased in 
FIGUrE 2: The acinar cells of Gnptab −/− mouse pancreas accumulate autolysosomes. (A–C) Ultrathin cryosections of 
wild-type and Gnptab −/− mouse exocrine pancreatic cells, immunogold labeled (10-nm gold particles) for LAMP-2.  
(A) Typical example of a LAMP-2 positive lysosome in wild-type (WT) cells. (B, C) Gnptab −/− pancreatic acinar cells 
accumulate numerous large LAMP-2 positive organelles that contain cytoplasmic material (asterisks), including  
(B) mitochondrial remnants and (C) secretory granules, which defines them as autolysosomes. The arrowheads in  
(C) show LAMP-2 labeling on the limiting membrane of the autolysosome, indicating that the secretory granule is 
enclosed within the autolysosome. (D) Another example of an autolysosome in Gnptab −/− pancreatic acinar cells that 
contains a secretory granule. The arrowheads indicate the membrane of the secretory granule, showing that the granule 
is inside the lumen of the autolysosome. (E, F) Immunogold labeling for amylase in (E) wild-type and (F) Gnptab 
−/− pancreas showing numerous secretory granules that appear similar in shape and density, albeit smaller in size in the 
Gnptab −/− cells. AL, autolysosome; G, Golgi apparatus; ISG, immature secretory granule; L, lysosome;  
M, mitochondrion; PM, plasma membrane; SG, secretory granule.
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granules with these compartments (microautophagy and crinophagy, 
respectively) were often observed, suggesting that these processes 
may be stimulated even though the degree of macroautophagy 
appears not to be (Figure 1, E–G).
The acinar cells of Gnptab −/− mice exhibit decreased 
lysosomal degradative capacity
Our EM analysis showed that the acinar cells of the mutant mice 
submandibular and pancreatic glands accumulate autolysosomes 
that are filled with autophagic substrates, that is, secretory granule 
and mitochondrial remnants. By Western blot, we determined that 
this defect was accompanied by an increase in the level of LC3-II, 
which was also detected in the parotid and sublingual salivary 
glands of the mutant mice (Figure 3A). LC3-II is the phosphatidyle-
thanolamine conjugated form of LC3-I that is formed upon recruit-
ment of LC3-I from the cytosol onto the autophagosomal mem-
brane during the process of autophagosome formation. After 
autophagosome closure, LC3-II on the surface of the autophago-
some is released back into the cytosol, whereas the luminal pool of 
LC3-II is normally degraded after fusion of the autophagosomes 
with the lysosomes (Pattingre et al., 2008). Because no obvious in-
duction of macroautophagy was detected in the mutant glands, and 
because our EM analysis showed that the fusion of autophago-
somes with lysosomes is not blocked in those tissues, the increase 
in the level of LC3-II strongly suggests a delay in its degradation 
within autolysosomes.
We also observed a striking increase in ubiquitinated proteins in 
the Gnptab −/− secretory glands compared with wild-type, espe-
cially in the mutant submandibular salivary gland and pancreas (Fig-
ure 3A). It was recently proposed that impaired progression of au-
tophagy delays the delivery in ubiquitinated substrates to the 
proteasome (Korolchuk et al., 2009), which could, at least in part, 
account for the increase of ubiquitinated proteins detected in the 
Gnptab −/− glands. In addition, because autophagy is a bulk deg-
radation process, ubiquitinated proteins present in the cytosolic 
portions that are engulfed within forming autophagosomes would 
be expected to accumulate secondary to a defect of autolysosomal 
degradation. Finally, the Gnptab −/− glands displayed a slight in-
crease in GAPDH, which is a substrate of chaperone-mediated au-
tophagy, a process by which cytosolic proteins are directly translo-
cated to the lysosomal lumen for degradation (Aniento et al., 1993) 
(Figure 3A). These findings are all consistent with a defect in the 
degradative function of the lysosomes.
To determine whether this decrease in lysosomal degradative ca-
pacity might be accounted for by a reduction in the acid hydrolase 
content in lysosomes, we measured the activity of a number of lyso-
somal glycosidases (Table 1). All of these glycosidases are known to 
acquire the Man-6-P recognition marker (Sleat et al., 2008), with the 
exception of β-glucocerebrosidase, which is targeted to the lyso-
somes by a Man-6-P–independent mechanism (Reczek et al., 2007). 
The activities of α-mannosidase, β-galactosidase, β-mannosidase, 
and β-glucuronidase were modestly decreased in the pancreas of the 
Gnptab −/− mice (39–61% of wild-type levels) and in the subman-
dibular salivary gland (28–89% of wild-type levels). The activity of 
α-galactosidase, however, was slightly elevated in both of these tis-
sues of the mutant mice, while the activity of β-hexosaminidase was 
greatly increased in the pancreas (13.2-fold) but modestly decreased 
in the submandibular salivary gland. β-Hexosaminidase, in contrast to 
the other five glycosidases, has been shown to be associated with the 
lysosomal membrane (Yadao et al., 1997; Magini et al., 2008), as is 
β-glucocerebrosidase, whose activity was increased in both −/− pan-
creas and salivary gland (2.7- and 2.1-fold, respectively). However, it 
number of autolysosomes in Gnptab −/− acinar cells (26.2 ± 3.1 
per cell profile vs. 1.5 ± 0.6 for the wild-type cells), as well as the 
decrease in the number of lysosomes (0.1 ± 0.1 in Gnptab −/− vs. 
2.7 ± 0.5 in wild-type), attained statistical significance (p < 0.01).
It should be noted, however, that in the Gnptab −/− mucous-
type secretory cells of the submandibular gland, engulfment of se-
cretory granules by autolysosomes and direct fusion of secretory 
FIGUrE 3: Steady-state levels of autophagy markers and lysosomal 
proteins in different tissues of wild-type and Gnptab −/− mice. (A) The 
levels of LAMP-2, LC3-II, and ubiquitinated proteins are greatly 
increased in the salivary and pancreatic glands of Gnptab −/− mice. 
Western blotting of the autophagy marker LC3 reveals that the level 
of the phosphatidylethanolamine-conjugated form of the protein, 
LC3-II, is highly increased in the parotid, sublingual, and 
submandibular salivary glands, as well as in the pancreas of the 
Gnptab −/− mice. An increase in the level of LAMP-2 is detected in 
the same organs, whereas the levels of both LC3-II and LAMP-2 are 
unchanged in the brain, liver, and muscle of the Gnptab −/− animals 
compared with wild-type levels. The immunoblot detection of 
ubiquitin shows that the levels of ubiquitinated proteins are modestly 
to strongly increased in the Gnptab −/− mouse salivary and 
pancreatic glands, while barely changed, if at all, in the brain and 
muscle of these mice compared with wild-type levels. A slight 
elevation of the level of ubiquitinated proteins is detected in the liver 
of the Gnptab −/− mice. The substrate of chaperone-mediated 
autophagy, GAPDH, is slightly increased in the exocrine secretory 
glands. (B) Cathepsin D levels as determined by Western blotting are 
similar in the Gnptab −/− submandibular salivary gland and slightly 
increased in the Gnptab −/− pancreas compared with wild-type levels. 
The mature enzyme is detected as a 39-kDa band, and partial 
processing to the heavy and light chain occurs in these tissues as 
shown by the presence of the 27-kDa band representing the heavy 
chain. Note that cathepsin D runs slightly slower in the Gnptab −/− 






























































α-Mannosidase 5.0 ± 0.6 7.6 ± 1.3* 1.52
β-Galactosidase 13.9 ± 4.4 8.5 ± 0.8* 0.61
α-Galactosidase 8.2 ± 1.0 5.8 ± 0.4* 0.71
β-Mannosidase 3.5 ± 0.5 3.7 ± 0.6 1.05
β-Glucuronidase 19.4 ± 2.4 26.4 ± 5.5* 1.36
β-Hexosaminidase 39.2 ± 5.2 55.6 ± 15.1* 1.42
β-Glucocerebrosidase 15.3 ± 6.4 26.4 ± 5.5* 1.73
Liver
α-Mannosidase 14.4 ± 5.1 26.8 ± 7.3* 1.86
β-Galactosidase 16.5 ± 6.9 25.3 ± 6.4* 1.54
α-Galactosidase 12.6 ± 2.0 18.1 ± 3.8* 1.44
β-Mannosidase 12.5 ± 2.5 23.1 ± 5.2* 1.85
β-Glucuronidase 83.6 ± 20.4 102.4 ± 3.5 1.22
β-Hexosaminidase 10.7 ± 3.3 33.7 ± 13.6* 3.16
β-Glucocerebrosidase 9.6 ± 3.4 14.2 ± 3.5* 1.47
Muscle
α-Mannosidase 1.6 ± 0.5 2.9 ± 0.7* 1.79
β-Galactosidase 1.4 ± 0.5 1.1 ± 0.6 0.79
α-Galactosidase 1.3 ± 0.3 1.1 ± 0.6 0.84
β-Mannosidase 1.2 ± 0.4 1.8 ± 0.5 1.47
β-Glucuronidase 10.2 ± 3.1 10.9 ± 2.8 1.07
β-Hexosaminidase 2.0 ± 0.7 2.1 ± 0.6 1.02
β-Glucocerebrosidase 1.6 ± 0.3 2.1 ± 0.5* 1.37
FIGUrE 4: Analysis of mTOR activity and Beclin-1 levels in wild-type and Gnptab −/− exocrine 
tissues. (A) Western blot showing the levels of Beclin-1 and the mTOR target p70S6K (total and 
phosphorylated) in wild-type and Gnptab −/− salivary glands (parotid, sublingual, and 
submandibular) and pancreas. Equal amounts of protein were loaded, as reflected by the equal 
levels of total p70S6K in each lane. Note the very slight increase in the level of Beclin-1, and the 
more pronounced increase in the amount of phosphorylated p70S6K, in the −/− tissues 
compared with wild-type levels. (B) Graph representing the quantification of the number of 
autolysosomes, autophagosomes, and lysosomes present detected per cell profile by EM in the 
pancreas of wild-type and Gnptab −/− mice. The number of autolysosomes and lysosomes are 
significantly increased and decreased in Gnptab −/− (p < 0.01), respectively, whereas the 























































α-Mannosidase 6.8 ± 2.0 3.9 ± 0.9* 0.57
β-Galactosidase 1.1 ± 0.2 0.7 ± 0.3* 0.61
α-Galactosidase 4.0 ± 0.7 6.0 ± 4.6 1.50
β-Mannosidase 66.6 ± 39.4 25.7 ± 9.6* 0.39
β-Glucuronidase 3.9 ± 0.6 2.2 ± 1.2* 0.57
β-Hexosaminidase 1.7 ± 0.5 22.8 ± 18.9* 13.2
β-Glucocerebrosidase 2.4 ± 0.7 6.5 ± 2.9* 2.70
Submandibular salivary gland
α-Mannosidase 2 124.5 ± 1500.9 589.6 ± 604.1* 0.28
β-Galactosidase 48.8 ± 15.2 20.5 ± 13.7* 0.42
α-Galactosidase 21.7 ± 4.5 27.9 ± 13.8 1.28
β-Mannosidase 34.5 ± 13.6 24.6 ± 12.6 0.71
β-Glucuronidase 79.5 ± 22.2 70.5 ± 24.9 0.89
β-Hexosaminidase 117.6 ± 44.8 86.5 ± 36.6 0.74
β-Glucocerebrosidase 6.7 ± 1.3 14.0 ± 6.6* 2.08
Fibroblasts
α-Mannosidase 8.6 ± 2.8 1.3 ± 0.3* 0.15
β-Galactosidase 23.7 ± 9.0 2.0 ± 0.7* 0.08
α-Galactosidase ND ND ND
β-Mannosidase 6.8 ± 2.0 1.1 ± 0.5* 0.16
β-Glucuronidase 31.0 ± 10.5 7.8 ± 2.8* 0.25
β-Hexosaminidase 34.9 ± 9.2 4.1 ± 1.7* 0.12
β-Glucocerebrosidase 24.1 ± 8.1 97.2 ± 29.8* 4.04
a Activities are expressed as nmol of methylumbellyferone released per mg protein per hour. 
The values are the average ± SD, with n ≥ 6.
*p < 0.01; ND, not determined.
TABLE 1: Activity of acid hydrolases in wild-type (WT) and Gnptab –/– tissues and fibroblasts.a
is not clear at this point that the membrane 
association of β-hexosaminidase is related to 
the increased activity in the −/− pancreas, 
nor is it clear how this association would af-
fect the targeting of this hydrolase.
We next determined the steady-state 
level of the protease cathepsin D in wild-
type and Gnptab −/− submandibular sali-
vary gland and pancreas by Western blot-
ting. As shown in Figure 3B, the level of 
cathepsin D was similar to wild-type or even 
slightly increased in these Gnptab −/− tis-
sues. In both tissues the major band was 
detected at ∼39 kDa, which corresponds to 
the mature form of the enzyme. Some of the 
mature cathepsin D was processed into the 
heavy and light chains, as shown by the 
presence of the ∼27-kDa heavy chain band. 
Cathepsin D had a slightly higher molecular 
weight in Gnptab −/− tissues, reflecting the 
differential processing of its N-linked 
glycans, which occurs in the absence of 
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The autolysosomes of the Gnptab −/− 
acinar cells contained low levels of cathep-
sin D labeling (Figure 5, E and F), consistent 
with dilution of the protease following fu-
sion of the lysosomes with the autophago-
somes. Because the total volume of autolys-
osomes in the Gnptab −/− acinar cells is so 
much larger than that of the lysosomes, a 
significant proportion of the total intracellu-
lar level of cathepsin D likely localizes to 
these compartments.
Loss of the Man-6-P signal does not 
affect tissues equally
Interestingly, in contrast to the exocrine 
glands of the Gnptab −/− mice, the liver, 
brain, and muscle of these mice contained 
normal levels of LAMP-2 and LC3-II (Figure 
3A) and did not exhibit generalized vacu-
olization when examined by light or electron 
microscopy. In addition, the level of ubiquit-
inated proteins and GAPDH was unchanged 
in the muscle and brain of the Gnptab −/− 
mice compared with wild-type levels. Thus, 
at this level of analysis, the loss of the Man-
6-P recognition system does not appear to 
impair the functioning of the autophagy or 
lysosomal system in these tissues. The liver 
of the mutant mice did exhibit a modest in-
crease in the level of ubiquitinated proteins, 
although there was no accumulation of au-
tolysosomes detected in this organ by EM 
(Supplemental Figure 1, A–D), and the lev-
els of LC3-II and LAMP-2 were normal.
Direct enzyme assays revealed that the 
levels of the acid hydrolases in the brain 
and muscle of the Gnptab −/− mice were 
normal or even somewhat elevated com-
pared with wild-type levels (1.0–1.8-fold) 
with the exception of β-galactosidase and 
α-galactosidase, whose activities were 
modestly decreased in the −/− brain by 39 
and 29%, respectively (Table 1). The liver 
of the Gnptab −/− mice exhibited an increase in the activity of all 
the acid hydrolases measured (1.2–3.1-fold). To determine whether 
the acid hydrolases were actually in lysosomes, membrane fractions 
of brain and liver (from wild-type or Gnptab −/− mice) were frac-
tionated on 18% self-forming Percoll density gradients as described 
previously (Boonen et al., 2009), a technique that allows concen-
tration of lysosomes in the densest fraction of the gradient (Fig-
ure 6), while the other organelles remain in the lighter fractions 
(Supplemental Figure 2). The analysis of the distribution of three 
different acid hydrolases (β-hexosaminidase, α-galactosidase, and 
α-mannosidase) revealed that a similar proportion of acid hydro-
lases localized to the dense-lysosome fraction in both organs, indi-
cating that the lysosomes of Gnptab −/− brain and liver receive 
normal levels of acid hydrolases (Figure 6).
Skin fibroblasts of Gnptab −/− mice accumulate lysosomes 
and/or autolysosomes deficient in acid hydrolases
Because the presence of “inclusions” in fibroblasts of mucolipi-
dosis type II patients is the hallmark of the disorder (also called 
phosphorylation of high-mannose–type sugar chains (Gelfman 
et al., 2007).
The intracellular localization of cathepsin D in wild-type and 
Gnptab −/− pancreatic acinar cells was then evaluated by immuno-
EM. Cathepsin D was readily detected in LAMP-1 positive late en-
dosomes and lysosomes of cells of both types of mice (Figure 5, 
A–D) and in the autolysosomes of the Gnptab −/− acinar cells (Fig-
ure 5, E and F). By quantification, the endolysosomes of wild-type 
cells contained 11.3 ± 11.6 gold particles per compartment, whereas 
lower values (5.3 ± 4.6 gold particles per compartment) were mea-
sured in the Gnptab −/− endolysosomes (p = 0.012). Moreover, we 
observed that the average surface area of the individual late-endo-
somal and lysosomal compartments in Gnptab −/− cells was 1.4× 
larger compared with wild-type levels. Consequently, the density of 
cathepsin D labeling in the late endosomes and lysosomes of the 
Gnptab −/− pancreatic acinar cells was reduced to 37% of the label-
ing density in wild-type cells (53.3 ± 50.1 vs. 144.5 ± 103.8 gold 
particles per μm2, respectively, p = 7.35 × 10−5), indicating decreased 
lysosomal targeting of cathepsin D in these cells.
FIGUrE 5: Lysosomes of Gnptab −/− pancreatic acinar cells contain reduced levels of cathepsin 
D. (A–F) Ultrathin cryosections of (A, B) wild-type and (C–F) Gnptab −/− pancreatic acinar cells 
immunogold labeled for cathepsin D (10-nm gold particles) and LAMP-1 (15 nm). (C, D) The 
endolysosomes in Gnptab −/− cells contain less cathepsin D compared with (A, B) wild-type 
cells. (E, F) Autolysosomes in Gnptab −/− pancreatic acinar cells contain low levels of cathepsin 
D. AL, autolysosome; L, lysosome; LE, late endosome.
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(Aula et al., 1975). Therefore we isolated 
skin fibroblasts from the Gnptab −/− mice 
and examined them by immuno-EM. 
Figure 7A shows strong labeling of the 
lysosomal protease cathepsin D in skin fi-
broblasts of wild-type mice. Lysosomes 
with a diameter of 400–600 nm were de-
 tected, containing lamellar material as 
well as small internal membrane vesicles. 
By contrast, the fibroblasts derived from 
the Gnptab −/− mice had increased num-
bers of lysosomes that contained very low 
levels of cathepsin D (Figure 7B) but were 
positive for the lysosomal membrane pro-
tein LAMP-2 (Figure 7, C and D). This defi-
ciency of cathepsin D reflects the known 
hypersecretion of this protease by this cell 
type (Lee et al., 2007). The lysosomes 
were enlarged (up to ∼1.5 μm in diameter), 
filled with dense amorphous material, and 
occupied much of the cytoplasm (Figure 
7C). Mitochondrial remnants were occa-
sionally detected within these compart-
ments, indicating that they had received 
material via the autophagic pathway and 
had become autolysosomes (Figure 7D). 
The difference in size and composition of 
these enlarged lysosomes and autolyso-
somes (∼1.5 μm, mainly amorphous con-
tent) compared with their counterparts in 
the exocrine tissues (up to 4 μm with nu-
merous organelle remnants) might explain 
why the latter gave rise to vacuolization 
that is readily detectable in paraffin sec-
tions while the other did not.
Measurements of the activity of five lys-
osomal hydrolases revealed extremely low 
levels in the Gnptab −/− fibroblasts (8–25% 
of wild-type levels), whereas the activity of 
β-glucocerebrosidase was increased four-
fold over wild-type levels (Table 1). The 
Gnptab −/− fibroblasts also showed in-
creased levels of LAMP-2 and LC3-II, as 
well as a slight increase in ubiquitinated 
proteins compared with wild-type fibro-
blasts (Figure 8, A and B). No difference in 
the level of GAPDH was detected, suggest-
ing that the process of chaperone-medi-
ated autophagy was not impaired in those 
cells. As in the exocrine glands, the level 
of phosphorylation of the mTOR target 
p70S6K was elevated in the Gnptab −/− fi-
broblasts compared with wild-type levels, 
indicating inhibition rather than activation 
of the macroautophagy pathway (Figure 8C). The cellular level of 
Beclin-1 was unchanged (Figure 8C).
These findings show that the Gnptab −/− fibroblasts accu-
mulate enlarged lysosomes and/or autolysosomes, most likely 
secondary to the severe depletion of acid hydrolases that impairs 
the degradative function of the lysosomes and autolysosomes. A 
similar decrease in acid hydrolase content was reported in fibro-
blasts isolated from mucolipidosis type II patients and from a 
I-cell disease for inclusion-cell disease), we were surprised that we 
did not detect morphological alterations in the fibrocytes and fi-
broblasts examined during the histologic survey of the Gnptab −/− 
mouse tissues (Vogel et al., 2009). Subsequently, we became 
aware of a 1975 publication by Aula et al. reporting that fibro-
blasts in tissues from a human mucolipidosis II fetus had detect-
able inclusions when the samples were embedded in epoxy, but 
not in paraffin, the method used for our prior histologic analysis 
FIGUrE 6: The subcellular distribution of acid hydrolases in the brain and liver of wild-type and 
Gnptab −/− mice is similar in a self-forming Percoll density gradient. Wild-type or Gnptab −/− 
liver and brain were homogenized in isotonic sucrose with a Potter-Elvehjem homogenizer and 
centrifuged at 1000 g to prepare a postnuclear supernatant (PNS). The PNS was subjected to 
centrifugation at 35,000 rpm in a 50Ti rotor for 40 min at 4ºC to obtain a membrane fraction 
which was resuspended in isotonic sucrose and loaded on top of an 18% Percoll solution. 
Self-forming gradients were generated by centrifugation at 25,000 rpm in a SW55Ti rotor for 
40 min at 4ºC. Seven fractions were collected from the top (low density) to the bottom (densest 
fraction) and acid hydrolase content was determined by enzyme assays. Graphs represent the 
distribution of α-galactosidase, β-hexosaminidase, and α-mannosidase in wild-type (n = 3) or 
Gnptab −/− (n = 3) liver and brain, expressed as a percentage of the total activity recovered in 
each fraction.
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Gnptab knock-in mouse model of mucolipi-
dosis type II (Kornfeld and Sly, 2000; 
Kollmann et al., 2010). Moreover, Otomo 
et al. recently showed that fibroblasts of pa-
tients with mucolipidosis II accumulate au-
tolysosomes that can account for the inclu-
sions initially observed by light microscopy 
(Leroy and Demars, 1967; Otomo et al., 
2009).
DISCUSSION
We previously reported that acinar cells of 
the exocrine glands of Gnptab −/− (MLII) 
mice exhibit extensive vacuolization when 
examined by light microscopy (Gelfman 
et al., 2007; Vogel et al., 2009). These mor-
phological abnormalities are similar to those 
described in the exocrine pancreas, salivary 
glands, and gastric chief cells of several MLII 
patients (Elleder and Martin, 1998). On the 
basis of our analysis of the acinar cells of the 
salivary and pancreatic glands of Gnptab 
−/− mice, we now demonstrate that the 
vacuolization represents the accumulation 
of autolysosomes in the mucous and serous 
cells of these organs. Our data show that 
these autolysosomes are defective in degra-
dative capacity, accounting for their striking 
accumulation. Yet the involved exocrine 
glands retain substantial amounts of acid 
hydrolases despite the loss of the Man-6-P 
signal. This finding is in contrast to fibro-
blasts which have similar morphological al-
terations but extremely low levels of acid 
hydrolases due to massive hypersecretion of 
these enzymes.
These observations can be explained by 
considering the unique role of the Man-6-P 
sorting pathway in regulated secretory cells 
compared with other cell types (i.e., the fi-
broblasts). In fibroblasts, the newly synthe-
sized acid hydrolases are packaged at the 
TGN into clathrin-coated carriers by a Man-
6-P–dependent mechanism and transported 
to the lysosomes (Figure 9C). When the syn-
thesis of the Man-6-P signal is defective, as 
occurs in Gnptab −/− mice, the acid hydro-
lases are hypersecreted via the constitutive 
secretory pathway, resulting in very low cel-
lular levels of the hydrolases (Figure 9D) 
(Lee et al., 2007). In the regulated secretory 
cells (Figure 9A), a portion of the newly syn-
thesized acid hydrolases are similarly pack-
aged into clathrin-coated carriers at the 
TGN and transported to lysosomes. How-
ever, studies of pancreatic beta-cells have 
shown that the majority of the hydrolases 
escape entry into the clathrin-coated carri-
ers and instead enter immature secretory 
granules (ISGs) that bud from the TGN 
(Kuliawat and Arvan, 1994). During granule 
maturation, the Man-6-P–containing acid 
FIGUrE 7: Gnptab −/− mouse skin fibroblasts accumulate enlarged lysosomes and/or 
autolysosomes. (A) Electron micrograph of a typical lysosome in wild-type mouse skin fibroblasts 
immunogold labeled (10-nm gold particles) for cathepsin D. (B–D) Electron micrographs showing 
the accumulation of enlarged lysosomes and/or autolysosomes (asterisks) in Gnptab −/− mouse 
skin fibroblasts, recognized by their dense heterogeneous content, the occasional presence of 
(D) mitochondrial remnants, and (C, D) the detection of LAMP-2 in their membrane. (B) The 
enlarged lysosomes and autolysosomes contain low levels of cathepsin D. M, mitochondrion; 
PM, plasma membrane; *, swollen lysosome or autolysosome.
FIGUrE 8: The level of LC3-II is elevated in Gnptab −/− mouse skin fibroblasts, while 
stimulation of macroautophagy via the Beclin-1 or mTOR pathway is not detected. 
(A, B) Immunoblots showing the increased levels of (A) LC3-II and LAMP-2 and (B) ubiquitinated 
proteins in Gnptab −/− mouse skin fibroblasts over wild-type levels. (Two independent cell 
lysates are shown for each genotype, indicated as +/+ and −/− for wild-type and Gnptab 
−/− mice, respectively.) (C) Detection by Western blotting of Beclin-1, whose levels are 
unchanged between +/+ and −/− cells, and of the mTOR target p70S6K, which is slightly more 
phosphorylated in the −/− fibroblasts compared with wild-type cells. (A–C) The level of GAPDH 
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and even greater packaging of the hydro-
lases into ISGs. Most important, once the 
hydrolases enter the ISGs, they would not 
be retrieved by the Man-6-P–dependent 
system. This hypothesis is supported by the 
observations of Kuliawat et al., who re-
ported that the loss of one of the two MPRs 
in mice, the cation-dependent MPR, re-
sulted in a nearly fourfold increase in the 
presence of the precursor form of cathepsin 
B in the regulated secretory pathway of 
pancreatic beta-cells (Kuliawat et al., 1997). 
The lack of binding of acid hydrolases to 
both of the MPRs in Gnptab −/− mice exo-
crine cells would be expected to impair the 
sorting and retrieval of the acid hydrolases 
to lysosomes even more. As a result, their 
lysosomes would be deficient in acid hydro-
lases and unable to efficiently degrade ma-
terial derived from the endocytic and au-
tophagic pathways. The finding that the 
cathepsin D content of the pancreatic acinar 
cell lysosomes of Gnptab −/− mice is de-
creased to 37% of the wild-type levels 
whereas the total cellular content of this 
protease is normal or even increased is con-
sistent with this model.
In addition, the modest decrease in the 
intracellular levels of several other acid hy-
drolases suggests their increased secretion 
by the Gnptab −/− acinar cells, either via 
the constitutive secretory pathway and/or 
as the result of secretory granule fusion with 
the plasma membrane followed by release 
of their contents. It should be noted that the 
extent of this secretion could be underesti-
mated in our assay. The steady-state level of 
the acid hydrolases in the acinar cells is de-
termined by the rate of synthesis, the extent 
of secretion, and their half-life. Sardiello et 
al. reported that acid hydrolase synthesis is 
up-regulated in fibroblasts from patients 
with several forms of lysosomal storage dis-
eases (Sardiello et al., 2009). If acid hydro-
lase synthesis is increased in the acinar cells 
of the Gnptab −/− mice, this could help 
maintain the intracellular levels of some acid 
hydrolases in the face of significant hyperse-
cretion of these enzymes. Nevertheless the 
issue of entrapment in secretory granules 
would remain. Finally, because we only assayed for a limited num-
ber of acid hydrolases, we cannot exclude the possibility, although 
unlikely, that one particular acid hydrolase (out of the total 60 en-
zymes that reside in lysosomes) might be dramatically reduced in 
the lysosomes, leading to the impaired degradative capacity of 
these compartments.
Unfortunately we were unable to formally demonstrate the mis-
sorting of the acid hydrolases into mature secretory granules of the 
mutant cells. By immuno-EM using cathepsin D antibodies, we only 
observed background labeling of the secretory granules of wild-
type and mutant pancreatic acinar cells. In addition, homogeniza-
tion and subcellular fractionation of the Gnptab −/− pancreas 
hydrolases are then removed by a mechanism involving binding to 
Man-6-P receptors (MPRs) and incorporation into AP-1 and syntaxin-
6-positive clathrin-coated vesicles (CCVs) that bud from the ISGs 
and transport their cargo to endolysosomes (Tooze and Tooze, 
1986; Kuliawat et al., 1997; Klumperman et al., 1998; Dittié et al., 
1999). This process provides an “exit site” for acid hydrolases that 
enter the regulated secretory pathway, allowing retrieval to lyso-
somes. The inability to synthesize the Man-6-P marker in the Gnptab 
−/− mice would have several consequences in these cells (Figure 9B). 
At the TGN, the newly synthesized acid hydrolases would be poorly 
sorted into CCVs due to their inability to bind MPRs, which would 
result in increased secretion via the constitutive secretory pathway 
FIGUrE 9: Model for the consequences of the lack of the Man-6-P signal on the trafficking of 
acid hydrolases in fibroblasts and secretory cell types (salivary and pancreatic gland acinar cells). 
(A) In secretory cell types, acid hydrolases can reach the lysosomes by two pathways: direct 
sorting from the TGN, or retrieval from the ISGs that had incorporated a portion of the newly 
synthesized hydrolases while budding off the TGN. Both processes involve packaging of the 
hydrolases in CCVs by a Man-6-P–dependent mechanism. (B) In the absence of the Man-6-P 
signal (Gnptab −/− cells), the hydrolases either undergo constitutive secretion or are trapped 
within mature secretory granules due to the lack of retrieval from the ISGs. As a result, 
lysosomes (L) have low levels of acid hydrolases. The accumulation of autolysosomes (AL) in the 
salivary glands and pancreas of the Gnptab −/− mice is the consequence of the resulting 
defective lysosomal degradative capacity. (C) In normal fibroblasts, acid hydrolases are 
packaged into clathrin-coated transport carriers at the TGN and targeted to lysosomes (L) in a 
Man-6-P–dependent manner. (D) The loss of the Man-6-P signal in Gnptab −/− fibroblasts, and 
the subsequent lack of recognition of the hydrolases at the TGN, results in their hypersecretion 
via the constitutive secretory pathway. Consequently, lysosomes (L) and autolysosomes (AL) with 
low acid hydrolase content and poor degradative capacity accumulate.
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or elevated levels of acid hydrolases in the brain and muscle, a more 
likely explanation is that these tissues utilize an intracellular Man-6-
P–independent targeting pathway(s). This is consistent with previ-
ous studies demonstrating the existence of a Man-6-P–independent 
intracellular sorting pathway for cathepsin D in MLII lymphoblasts 
and thymocytes isolated from mice deficient in both Man-6-P recep-
tors (Glickman and Kornfeld, 1993; Glickman et al., 1996; Dittmer 
et al., 1999). A major goal of future work will be to identify the mo-
lecular basis of the Man-6-P–independent pathway(s).
MATERIALS AND METHODS
Materials
Chemicals, including fluorogenic substrates for acid hydrolase en-
zyme assays, were obtained from Sigma Aldrich (St. Louis, MO) 
unless otherwise specified. Mouse anti-ubiquitin antibody and 
rabbit anti–Beclin-1, p70S6K, and phospho-p70S6K (Thr389) anti-
bodies were purchased from Cell Signaling Technology (Danvers, 
MA). Rabbit anti-LC3 and mouse anti-GAPDH antibodies were ob-
tained from Novus Biologicals (Littleton, CO) and Sigma Aldrich, 
respectively, and both rat anti–LAMP-1 and rat anti–LAMP-2 
antibodies from Developmental Studies Hybridoma Bank (Iowa 
City, IA). Goat anti-amylase antibody was purchased from Santa 
Cruz Biotechnology (Santa Cruz, CA) and rabbit anti-amylase 
(AMY2B) from Proteintech Europe (Manchester, UK). The rabbit 
anti–cathepsin D used for Western blots was produced in our labo-
ratory. Cathepsin D was detected in immuno-EM with a rabbit 
anti–cathepsin D antibody that was a generous gift from M. Koike 
(Juntendo University Graduate School of Medicine, Tokyo, 
Japan). Horseradish peroxidase (HRP)–coupled secondary anti-
bodies were purchased from GE Healthcare (Piscataway, NJ). For 
immuno-EM, rabbit anti–rat immunoglobulin (Ig)G polyclonal an-
tibody (DAKO, Heverlee, Belgium) was used as a bridging step 
between rat monoclonal antibody (mAb) and protein A-gold (Cell 
Microscopy Center, UMC Utrecht, the Netherlands). Cellgro Alpha-
Minimum Essential Media and penicillin/streptomycin were ob-
tained from Fisher Scientific (Pittsburgh, PA) and fetal calf serum 
(FCS) from ISC BioExpress (Kaysville, UT). The Gnptab −/− mice 
were described previously (Gelfman et al., 2007).
Enzyme assays
Mouse skin fibroblasts were isolated from wild-type and 
Gnptab −/− mouse ears and maintained in α-MEM medium con-
taining 20% FCS, 100 μg/ml penicillin, and 100 U/ml streptomycin. 
Organs were collected from 3–4-mo-old mice after perfusion 
through the heart with phosphate-buffered saline (PBS) (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.5). 
Tissues or confluent cells in culture were suspended in PBS contain-
ing 1% Triton X-100 and a mixture of protease inhibitors (complete 
mini protease inhibitor tablets; Roche, Penzberg, Germany) for 
15 min on ice and then sonicated and centrifuged for 15 min at 
13,000 g. Lysosomal hydrolase activities were determined in the 
supernatants by fluorometric enzyme assays as described (Lee 
et al., 2007). Briefly, the samples were incubated with either 1 mM 
(tissue samples) or 5 mM (cultured fibroblasts lysates) of 4-methy-
lumbelliferyl–coupled specific substrates in a 50-mM citrate buffer 
containing 0.5% Triton X-100 (pH 4.5) at 37ºC, except for the 
β-glucocerebrosidase assay that was performed in a buffer contain-
ing 0.1 M sodium citrate, 0.2 M Na2HPO4, 0.2% TX-100, and 0.25% 
sodium taurocholate, pH 5.2. Reactions were stopped by addition 
of 0.1 M glycine-NaOH solution (pH 10.3) and the fluorescence was 
read at 495 nm. Activities were expressed as nanomoles of hydro-
lyzed methylumbelliferone per milligram protein and per hour.
resulted in extensive autolysosome disruption, which made it im-
possible to determine whether the secretory granules in the mutant 
pancreas contained increased amounts of acid hydrolases. Meister 
et al. recently reported this same problem with pancreatic tissue of 
cation-independent MPR–deficient mice (Meister et al., 2010). Simi-
lar to our work, these authors described the formation of large cyto-
plasmic vacuoles in the pancreas of those mice, although much less 
severe than in the Gnptab −/− mice (Gelfman et al., 2007).
We did not detect convincing evidence for macroautophagy ac-
tivation in the exocrine glands of the Gnptab −/− mice (3–4-mo-old 
mice), based on evaluation of Beclin-1 levels and activity of mTOR. 
However, we cannot rule out the possibility that stimulation of mac-
roautophagy may have contributed to pathological development at 
an earlier stage of the process. In addition, the numerous profiles of 
ongoing crinophagy and microautophagy observed in the mutant 
salivary glands raise the possibility that these processes may be 
stimulated, perhaps representing an attempt to dispose of secre-
tory granules that have been damaged by their content of acid hy-
drolases. This activation could contribute to the accumulation of 
autolysosomes. In the Gnptab −/− pancreas, the accumulation of 
autolysosomes was accompanied by a decrease in the number of 
lysosomes. These data are consistent with the recent report that 
inhibition of autolysosomal protein degradation with protease in-
hibitors abrogates lysosome reformation, leading to the accumula-
tion of enlarged and long-lived autolysosomes (Yu et al., 2010). The 
accumulation of autolysosomes in our MLII mouse also points out 
an important difference compared with other lysosomal storage 
disorders with autophagy defects, including multiple sulfatase defi-
ciency and mucopolysaccharidosis IIIA. Studies of mouse models of 
these disorders revealed that the affected cells exhibit an accumula-
tion of autophagosomes, rather than autolysosomes, resulting from 
a defect in the fusion of the autophagosomes with lysosomes 
(Settembre et al., 2008; Fraldi et al., 2010). By contrast, the defect 
in the Gnptab −/− mice appears to be the failure to dispose of the 
engulfed material by lysosomes and autolysosomes deficient for 
critical lysosomal hydrolases.
Our data support previous reports that the requirement for the 
Man-6-P–dependent sorting pathway varies substantially among 
cell types. At one extreme, fibroblasts (cells of mesenchymal origin) 
are highly dependent on the Man-6-P pathway for efficient acid hy-
drolase sorting and lysosomal function. Our findings now demon-
strate that the lysosomal function of the exocrine secretory cells is 
also highly dependent on the Man-6-P pathway. It is of note that 
exocrine secretory cells and organs, including the pancreas, appear 
to have a relatively high basal level of autophagy compared with 
other tissues (Mizushima et al., 2004). This might explain why the 
autolysosomes detected in the exocrine cells of the Gnptab −/− 
mice were generally more prevalent than observed in fibroblasts 
and often filled with easily recognizable remnants of material de-
rived from macro-, micro-, or crinophagy. At the other extreme, the 
liver, brain, and muscle of the Gnptab −/− mice have normal or even 
elevated levels of acid hydrolases that are correctly localized within 
lysosomes, despite the loss of the Man-6-P signal, and do not ex-
hibit any obvious morphological alterations. These findings are in 
agreement with those previously reported for postmortem samples 
obtained from patients with MLII (Kenyon et al., 1973; Martin et al., 
1975, 1984; Nagashima et al., 1977; Owada and Neufeld, 1982; 
Waheed et al., 1982). The liver, which is known to have a high endo-
cytosis capacity, had an increased level of all the measured acid hy-
drolases, which could reflect their capture from the plasma where 
the levels are extremely elevated in the mutant mice (Gelfman et al., 
2007). However, while endocytosis might contribute to the normal 
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Percoll density gradients
Wild-type and Gnptab −/− mice that were 2–3 mo of age were 
anesthetized and subsequently perfused with PBS to remove blood 
from their organs. The brains and livers of these mice were removed 
and fractionated on an 18% self-forming Percoll density gradient as 
described previously (Boonen et al., 2009). Briefly, a membrane frac-
tion was prepared, loaded on top of an 18% Percoll solution (18% 
[vol/vol] Percoll [Pharmacia, Uppsala, Sweden], 0.25 M sucrose, 
2 mM EDTA, and 10 mM Tris/HCl [pH 7.4]) and centrifuged at 
25,000 rpm in a Beckman SW55Ti rotor for 40 min at 4ºC. Seven 
fractions were collected from the top of the gradient. The distribu-
tion of three different lysosomal hydrolases was determined by en-
zyme assays as described earlier.
Western blotting
Identical amounts of wild-type or Gnptab −/− protein samples (ly-
sed in PBS containing 1% Triton X-100 and protease inhibitors as 
described earlier) were resolved on polyacrylamide gels and 
transferred onto polyvinylidene fluoride membranes (Millipore, 
Billerica, MA), which then were blocked in 10% fat-free milk in 
PBS/Tween 0.1% for 30 min at room temperature (RT) prior to in-
cubation overnight at 4ºC with primary antibodies diluted in PBS/
Tween 0.1% containing 0.2% fat-free milk. After washing with PBS/
Tween 0.1%, blots were incubated for 45 min at RT with HRP-cou-
pled secondary antibodies diluted in PBS/Tween 0.1% containing 
0.2% fat-free milk and washed. Immunoreactive bands were re-
vealed by chemiluminescence (ECL Amersham, Piscataway, NJ).
EM
Wild-type and Gnptab −/− mice at 1.5–2 mo of age were sedated 
and perfused via the heart with either 2% wt/vol paraformaldehyde 
(PFA) in 0.1 M phosphate buffer (PB) pH 7.4 or 2% wt/vol PFA, 0.2% 
wt/vol glutaraldehyde (GA, from Polysciences Europe GmbH, 
Eppelheim, Germany) in 0.1 M PB, pH 7.4. Following the perfusion 
fixation with 2% PFA, the tissues were removed and immediately 
immersed in 4% wt/vol PFA in 0.1 M PB and kept overnight at 4°C. 
In case of the perfusion fixation with 2% PFA, 0.2% GA, the tissues 
of interest were divided into two halves and either immersed in the 
same fixative, kept overnight at 4°C, and processed for cryosection-
ing or immersed in 2% wt/vol PFA, 2.5% wt/vol GA in Na-cacodylate 
buffer (Karnovsky fixative) for 2 h at RT. Subsequently, the Karnovsky 
fixative was replaced for 0.1 M Na-cacodylate buffer, pH 7.4. Prior 
to Epon embedding, the tissues were postfixed with 1% wt/vol 
OsO4, 1.5% wt/vol K3Fe(III)(CN)6 in 0.065 M Na-cacodylate for 2 h 
at 4°C. Subsequently the tissues were stained with 0.5% uranyl ac-
etate for 1 h at 4°C, dehydrated with ethanol, and embedded in 
Epon. Ultrathin sections were stained with uranyl acetate and lead 
citrate.
For cryosectioning and immuno-EM, the fixed tissues were fur-
ther processed as described (Slot and Geuze, 2007). In short, the 
tissues were cut into small blocks, rinsed with PBS and PBS contain-
ing 0.02 M glycine, and embedded in 12% gelatin. The blocks were 
incubated overnight in 2.3 M sucrose at 4°C, mounted on metal 
pins, and frozen in liquid nitrogen. Ultrathin cryosectioning was per-
formed at −120°C in a Leica UCT-FCS ultracryomicrotome (Leica 
Microsystems, Vienna, Austria). The sections were transferred to 
copper grids by pickup with a 1:1 mixture of 2.3 M sucrose in PBS 
and 2% wt/vol methyl cellulose. For immunogold labeling, the grids 
were incubated first on 2% gelatin/PBS at 37°C, blocked with 
0.02 M glycine/PBS and 1% bovine serum albumin/PBS, and subse-
quently incubated with primary antibodies followed by protein 
A-gold. The sections were contrasted with 2% uranyl acetate/ox-
alate, pH 7, followed by 0.4% uranyl acetate pH 4 and 1.8% methyl 
cellulose (Slot and Geuze, 2007).
Mouse skin fibroblasts were fixed by addition of an equal volume 
of 4% wt/vol PFA in 0.1 M PB to the culture medium. After ∼10 min, 
the fixative was replaced for 4% wt/vol PFA in 0.1 M PB for at least 
2 h at RT and the cells were processed for cryosectioning and im-
munogold labeling.
All sections were analyzed in a JEOL 1200 EX (Tokyo, Japan) 
electron microscope at 60 or 80 kV for Epon or cryosections, respec-
tively. Quantification of the number of autophagosomes, autolyso-
somes, and lysosomes was performed in ultrathin cryosections of 
wild-type and Gnptab −/− pancreas labeled for LAMP-2. Values are 
average numbers per cell profile ± SE of the mean. Autophago-
somes were defined as compartments containing cytoplasmic ma-
terial but that were devoid of LAMP-2 labeling. Autolysosomes were 
distinguished by the presence of undegraded cytoplasmic material 
and the presence of LAMP-2 on their limiting membrane, whereas 
lysosomes were defined as LAMP-2–positive compartments with 
homogeneous content that occasionally contained visible internal 
membrane sheets. In total, 15 cell profiles from two grids of wild-
type or Gnptab −/− pancreatic acinar cells were assessed for the 
presence of lysosomes and autolysosomes and 30 cell profiles 
for the presence of autophagosomes. Quantification of the cathe-
psin D labeling in late endosomes and lysosomes of wild-type and 
Gnptab −/− pancreatic acinar cells was performed by random 
screening of LAMP-1 and cathepsin D double-labeled sections. Late 
endosomes and lysosomes were defined as LAMP-1–positive com-
partments with a diameter size >200 nm that were devoid of unde-
graded autophagic material. The number of gold particles repre-
senting cathepsin D was scored per compartment. In total, 29 
endolysosomal compartments were assessed in both wild-type and 
Gnptab −/− cells, out of which the average cathepsin D labeling 
level was determined; ± values are standard deviations. The surface 
of the late endosomes and lysosomes was measured with a square 
lattice overlaying the electron micrographs by counting the number 
of points within the compartment (point hit method, Griffiths, 1993). 
The mesh size of the square lattice was adjusted to the magnifica-
tion of the electron micrographs: 7.5, 10.28, and 12.45 mm for mag-
nifications of 30,000×, 40,000×, and 49,000×, respectively. The 
labeling density of cathepsin D was calculated by dividing the num-
ber of gold particles for cathepsin D by the product of the number 
of points and the area associated with one point (0.0088 μm2). In this 
way the numerical density of gold over an area was obtained in gold 
particles per μm2 (Griffiths, 1993). The size of the secretory granules 
in wild-type and Gnptab −/− pancreatic acinar cells was determined 
by using the same point hit method. In total, 165 and 211 secretory 
granules were evaluated in the wild-type and Gnptab −/−, respec-
tively. P values were determined by performing a t test.
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